and Holarrhena antidysenterica (Seed) were taken for study.The result showed that out of nine tested plants, four plant extracts (44%) showed activity against at least five or more tested bacteria and five plant extracts (56%) were active against three or less than three bacteria. None of the tested plant extracts was active against all the tested bacteria. A. racemosus was the least effective against bacterial species. S. aureus was the most susceptible bacteria being sensitive to 18 extracts from 9 medicinal plants. P. vulgaris was the most resistant bacteria being resistant to all selective plants. The MBC value ranges from 3.12 mg/ml to >50 mg/ml. Lowest MBC was shown by ethylacetate extract of T. bellirica against E. coli and ethylacetate extract of W. fruticosa against S. dysenteriae. Largest ZOI (31 mm) was produced by ethylacetate extract of T. bellirica.
Introduction
Plants and plant products have been a source of food and medicines from the dawn of human civilization. The earliest mention of medicinal use of plants on Indian subcontinent has been found in the Rigveda which was written between 4500-1600 BC (HMG 1993) . Nepal Himalaya, globally significant and biologically diverse ecosystem is rich in varieties of medicinal plants. Among the 7000 species of medicinal plants recognized all over the world, more than 900 types of precious medicinal plants are said to be found in Nepal (Manandhar 2000) . In Nepal, about 75-80% of the rural populations use these traditional remedies (HMG 2007) . The knowledge about the use of medicinal plants is deeply rooted in the traditional and culture of Nepalese people living in rural areas (Rijal 1994 ).
Infectious diseases caused by baceria, fungi, viruses and parasites are still a major threat to public health, despite the tremenodous progress in human medicine. The clinical efficacy of many existing antibiotics is being threatened by the emergence of multi-drug resistant pathogens (Kumar et al. 2002) . Bacterial and fungal pathogens have evolved numerous defense mechanisms against anti-microbial and resistance to old and newly produced drugs is on rise. This increase has been attributed to indiscriminate use of broadspectrum antibiotics and immunosuppressive agent (Kokoska et al.2002) . In addition, in developing countries, synthetic drugs are not only expensive and inadequate for the treatment of diseases but also often with adulterations and side effects. Therefore, there is need to search new infection-fighting strategies to control microbial infections (Sieradzki et al. 1999) . Innumerable biologically active compounds are found in plants that posses antimicrobial properties which represent a vast untapped source of medicines (Branter & Grein 1994) . These active compounds are found in various parts such as root, shoot, bark, fruit and sometime throughout whole plant. 
Extraction of plant materials
Finely powdered plant parts were subjected to continuous extraction from three different solvents viz hexane, ethylacetate and methanol in the order of increasing polarity, by using soxhlet apparatus to obtain crude extract viz hexane extract, ethylacetate extract and methanol extract respectively. After complete extraction, the solvent will be totally removed by using rotary evaporator and these extracts were separately assayed for their antibacterial activity.
Prepation of stock/working solution
Stock solution (100 mg/ml) of each crude extract was made by dissolving 1 g of extract in 10 ml of dimethyl sulphoxide (DMSO) in clean and capped test tubes, which were sealed and stored in refrigerator (2-8°C) until use. 
Collection of standard culture

Antibacterial activity assay
The antibacterial activity of crude extract of medicinal plants was screened against the test organism by agar well diffusion method as given by Dingle et al. (1953) . The bacterial isolates were first grown in a nutrient broth and standardized to 0.5 Mc Farland (10 6 CFU/ ml). Inoculums containing 10 6 CFU/ml of bacteria were A.calamus Ea  26  20  --15  14  ---26  Me  -16  12  ------23  4 T. bellerica He  ----------Ea  31  18  -13  18  -15  --17  Me  21  19  -------19  5 T. chebula
A. marmelos He  -13  --------Ea  -16  12  ------18  Me  -12  12  -----20 spread on the solid Muller-Hinton Agar (MHA) plates with a sterile cotton swabs moistened with the bacterial suspension. Wells were made in plates using sterile cork borer (8 mm diameter). The working suspension/ solution (100µl ) of different medicinal plant extracts (100mg/ml) and same volume of DMSO as a control were filled in the wells with the help of micropipettes. The plates were left for sometime so that the extracts diffused into media and they were incubated at 37°C for 24 hours. After overnight incubation, the plates were observed for zone of inhibition (ZOI) and diameter of ZOI were scaled and were recorded. The triplicate assay was performed in case of the presence of Zone of inhibition. Then the mean of ZOI was recorded.
Determination of minimum bactericidal concentration (MBC)
The crude extracts of different fractions of medicinal plants, which showed antibacterial activity were then subjected to two fold serial dilution method as described by Baron et al. (1994) to determine minimum bactericidal concentration (MBC).
Results and Discussion
In this study, 27 extracts obtained by continuous extraction from 9 different plants using hexane, ethylacetate and methanol solvents in the order of increasing polarity were studied for their antimicrobial 
H. antidysentrica 
T. cordifolia
A. racemosus
A. marmelos (2007), where none of the tested bacteria was inhibited by M. pudica. Ethylacetate extracts of T. bellirica inhibited the growth of 6 bacterial species, methanol extract inhibited 3 bacterial species while hexane fraction did not inhibit any tested bacterial species, which was similar to the result showed by Ahmad (1998) . The result showed that the active compounds might be polar compounds. From this study it can be concluded that the selected medicinal plants had antibacterial activity against common pathogenic bacterial species.
